Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
References
1. Mark Powzaniuk, Sheila McElwee-Witmer, Robert L. Vogel, Tadashi Hayami, Su Jane Rutledge, Fang Chen, Shun-ichi Harada, Azriel Schmidt, Gideon A. Rodan, Leonard P. Freedman, and Chang Bai. The LATS2/KPM Tumor Suppressor Is a Negative Regulator of the Androgen Receptor. Mol. Endocrinol., Aug 2004; 18: 2011-2023. 2. Naohiko Anzai, Hiroki Miyazaki, Rie Noshiro, Suparat Khamdang, Arthit Chairoungdua, Ho-Jung Shin, Atsushi Enomoto, Shinichi Sakamoto, Taku Hirata, Kimio Tomita, Yoshikatsu Kanai, and Hitoshi Endou. The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C-terminal. J. Biol. Chem., Aug 2004; 10.1074/jbc.M406724200. 3. Pierfrancesco Tassone, Victor S Goldmacher, Paola Neri, Antonella Gozzini, Masood A Shammas, Kathleen R Whiteman, Linda Hylander, Daniel R Carrasco, Teru Hideshima, Reshma Shringarpure, Jialan Shi, Charles K Allam, John Wijdenes, Salvatore Venuta, Nikhil C Munshi, and Kenneth C Anderson. Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ Multiple Myeloma cells. Blood, Aug 2004; 10.1182/blood-2004-03-0963. 4. Kazuishi Kubota, Kaori Nakahara, Toshiaki Ohtsuka, Shuku Yoshida, Junko Kawaguchi, Yoko Fujita, Yohei Ozeki, Ayako Hara, Chigusa Yoshimura, Hidehiko Furukawa, Hideyuki Haruyama, Kimihisa Ichikawa, Makoto Yamashita, Tatsuji Matsuoka, and Yasuteru Iijima. Identification of 2'-phosphodiesterase, which plays a role in the 2-5A system regulated by interferon. J. Biol. Chem., Jun 2004; 10.1074/jbc.M400089200. 5. Tomoaki Tanaka, Edward T. H. Yeh, and Tetsu Kamitani. NUB1-mediated targeting of the ubiquitin precursor UbC1 for its C-terminal hydrolysis. Eur. J. Biochem., Mar 2004; 271: 972 - 982. 6. Ryoko Iizuka, Katsuyoshi Chiba, and Shinobu Imajoh-Ohmi. A Novel Approach for the Detection of Proteolytically Activated Transglutaminase 1 in Epidermis Using Cleavage Site-Directed Antibodies. J. Invest. Dermatol., Sep 2003; 121: 457 - 464. 7. Daisuke Kobayashi, Takashi Nozawa, Kozue Imai, Jun-ichi Nezu, Akira Tsuji, and Ikumi Tamai. Involvement of Human Organic Anion Transporting Polypeptide OATP-B (SLC21A9) in pH-Dependent Transport across Intestinal Apical Membrane. J. Pharmacol. Exp. Ther., Aug 2003; 306: 703 - 708. 8. Daisuke Kobayashi, Takashi Nozawa, Kozue Imai, Jun-ichi Nezu, Akira Tsuji, and Ikumi Tamai. Involvement of Human Organic Anion Transporting Polypeptide OATP-B (SLC21A9) in pH-Dependent Transport across Intestinal Apical Membrane. J. Pharmacol. Exp. Ther., Apr 2003; 103051300. 9. Takehiko Ogura, Tetsushi Furukawa, Tetsuya Toyozaki, Katsuya Yamada, Ya-Juan Zheng, Yoshifumi Katayama, Haruaki Nakaya, and Nobuya Inagaki. ClC-3B, a novel ClC-3 splicing variant that interacts with EBP50 and facilitates expression of CFTR-regulated ORCC. FASEB J, Apr 2002; 108451. 10. Hisayuki Nomiyama, Kunio Hieshima, Takashi Nakayama, Tomonori Sakaguchi, Ryuichi Fujisawa, Sumio Tanase, Hiroshi Nishiura, Kenjiro Matsuno, Hiroshi Takamori, Youichi Tabira, Tetsuro Yamamoto, Retsu Miura, and Osamu Yoshie. Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes. Int. Immunol., Aug 2001; 13: 1021 - 1029.USBio References
No references available